Prognostic Relevance of FOS and JUN Family Members and Immune Cell Infiltration for the Survival of Patients With Ovarian Carcinoma
{{output}}
Background/aim: Ovarian carcinoma is a difficult-to-treat cancer. It is often resistant to chemotherapy and targeted therapy. The 5-year survival rates of patients with advanced tumors are usually below 40%. Immunotherapy represe... ...
